Expert Consensus Decision Pathway
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee

https://doi.org/10.1016/j.jacc.2020.05.037Get rights and content
Under an Elsevier user license
open archive

Key Words

ACC Expert Consensus Decision Pathway
atherosclerotic cardiovascular disease
cardiovascular risk reduction
diabetes
GLP-1RA
SGLT2 inhibitor
type 2 diabetes

Cited by (0)

Endorsed by the American Diabetes Association

This document was approved by the American College of Cardiology Clinical Policy Approval Committee in June 2020.

The American College of Cardiology requests that this document be cited as follows: Das SR, Everett BM, Birtcher KK, Brown JM, Januzzi Jr JL, Kalyani RR, Kosiborod M, Magwire ML, Neumiller JJ, Morris PB, Sperling LS. 2020 Expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol 2020;76:1117–45.

Copies: This document is available on the World Wide Web site of the American College of Cardiology (www.acc.org). For copies of this document, please contact Elsevier Inc. Reprint Department via fax (212) 633-3820 or e-mail ([email protected]).

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology. Requests may be completed online via the Elsevier site (https://www.elsevier.com/about/policies/copyright/permissions?).